These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11360038)

  • 21. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
    Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
    J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.
    Fisher DS; Beyer C; van Schalkwyk G; Seedat S; Flanagan RJ
    Ther Drug Monit; 2017 Apr; 39(2):109-117. PubMed ID: 28125503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive determination of sulpiride in human plasma by high-performance liquid chromatography.
    Tokunaga H; Kudo K; Jitsufuchi N; Ohtsuka Y; Imamura T
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):203-7. PubMed ID: 9140776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    Acta Psychiatr Scand; 2009 Dec; 120(6):416-28. PubMed ID: 19573049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation].
    Lande G; Drouin E; Gauthier C; Chevallier JC; Godin JF; Chiffoleau A; Le Marec H
    Ann Fr Anesth Reanim; 1992; 11(6):629-35. PubMed ID: 1363741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of antipsychotic drugs in psychiatric inpatients.
    Tokunaga H; Kudo K; Imamura T; Jitsufuchi N; Ohtsuka Y; Ikeda N
    Nihon Hoigaku Zasshi; 1997 Dec; 51(6):417-22. PubMed ID: 9545754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.
    Hamon-Vilcot B; Chaufour S; Deschamps C; Canal M; Zieleniuk I; Ahtoy P; Chretien P; Rosenzweig P; Nasr A; Piette F
    Eur J Clin Pharmacol; 1998 Jul; 54(5):405-9. PubMed ID: 9754984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sultopride on prolactin secretion in rats.
    Mizuchi A; Kitagawa N; Saruta S; Tokuda H; Miyachi Y
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):232-40. PubMed ID: 6424592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of sultopride in a case of neuroleptic-induced late dyskinesia].
    Leclere A; Plichart P
    Sem Hop; 1982 Nov; 58(42):2492-3. PubMed ID: 6130603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sultopride: a new powerful neuroleptic (author's transl)].
    Anglade P; Baraer J
    Sem Hop; 1979 Jan 8-15; 55(1-2):63-7. PubMed ID: 34217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prandial effect on the systemic exposure of amisulpride.
    Jang YJ; Jeong TC; Noh K; Baek IW; Kwon KI; Kim E; Yoon YR; Kang W
    Arch Pharm Res; 2014 Oct; 37(10):1325-8. PubMed ID: 24469600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 36. [Torsades de pointes during sultopride poisoning].
    Montaz L; Varache N; Harry P; Aymes C; Turcant A; Delille F; Simonin D; Hass C
    J Toxicol Clin Exp; 1992 Dec; 12(8):481-6. PubMed ID: 1364061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study.
    Müller MJ; Härtter S; Köhler D; Hiemke C
    Pharmacopsychiatry; 2001 Jan; 34(1):27-32. PubMed ID: 11229619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study using double-blind method of sultopride and thioproperazine].
    Sizaret P; Moreau C
    Encephale; 1977; 3(2):111-20. PubMed ID: 19230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol.
    Yasui-Furukori N; Saito M; Furukori H; Inoue Y; Someya T; Kaneko S; Tateishi T
    Ther Drug Monit; 2004 Jun; 26(3):336-41. PubMed ID: 15167638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring.
    Gschwend MH; Arnold P; Ring J; Martin W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):132-9. PubMed ID: 16386474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.